FDA Approves Combo Treatment for Stomach, GE Junction Adenocarcinoma
The US Food and Drug Administration (FDA) today approved a new combination treatment for patients with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma.
Blood Clots a Common Risk for Some Cancer Patients
As if cancer treatment isn't rigorous enough, patients are often at risk of additional medical problems for months afterwards. New research has uncovered that some cancer patients face an increased risk of developing blood clots.